Literature DB >> 6135930

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.

M E Appleyard, A D Smith, G K Wilcock, M M Esiri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6135930     DOI： 10.1016/s0140-6736(83)90409-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data.

Authors:  K J Reinikainen; P J Riekkinen; L Paljärvi; H Soininen; E L Helkala; J Jolkkonen; M Laakso
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

2.  Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome.

Authors:  R Crols; J Saerens; M Noppe; A Lowenthal
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

3.  Acetylcholine synthesis in human CSF: implications for study of central cholinergic metabolism.

Authors:  S T DeKosky; S W Scheff; C G Hackney
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

4.  Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.

Authors:  M E Appleyard; B McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

5.  Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.

Authors:  M Ruberg; A Villageois; A M Bonnet; B Pillon; F Rieger; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

6.  Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.

Authors:  J Jolkkonen; H Soininen; T Halonen; A Ylinen; V Laulumaa; M Laakso; P Riekkinen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

7.  Altered levels of acetylcholinesterase in Alzheimer plasma.

Authors:  María-Salud García-Ayllón; Iolanda Riba-Llena; Carol Serra-Basante; Jordi Alom; Rathnam Boopathy; Javier Sáez-Valero
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.